AC
BOLD

Almitas Capital’s Boundless Bio BOLD Stock Holding History

Almitas Capital’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-86,808
Closed -$107K – 118
2025
Q3 		$107K Sell
86,808
-148,697
-63% -$172K 0.02% 62
2025
Q2 		$238K Buy
235,505
+1,127
+0.5% +$1.5K 0.06% 71
2025
Q1 		$354K Buy
234,378
+42,371
+22% +$87.8K 0.12% 69
2024
Q4 		$557K Buy
+192,007
New +$559K 0.12% 67

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Almitas Capital's BOLD Position: Q4 2025 in Review

Almitas Capital sold out of Boundless Bio (BOLD) in Q4 2025, closing a stake of 86,808 shares — an estimated $107K sold.

Almitas Capital first reported a position in BOLD in Q4 2024 and held it in 4 quarters. The position peaked at $557K in Q4 2024. 36 funds tracked by Wall St. Rank hold BOLD as of Q4 2025.

  • Almitas Capital reported no remaining Boundless Bio position as of Q4 2025 after selling out during the quarter.
  • Almitas Capital sold 86,808 Boundless Bio shares in Q4 2025, an estimated $107K.
  • Almitas Capital first reported a position in Boundless Bio in Q4 2024 and held it in 4 quarters.
  • Almitas Capital's Boundless Bio position peaked at $557K in Q4 2024.
  • 36 funds tracked by Wall St. Rank held Boundless Bio as of Q4 2025.

Based on Almitas Capital's 13F filing for Q4 2025, filed 17 Feb 2026.